Effects of some calcium antagonists upon the activity of common antiepileptic compounds on sound-induced seizures in DBA/2 mice

General Pharmacology

Volumn 23, Issue 1, 1992, Pages 75-82

  De Sarro, G B ^a   De Sarro, A ^b   Trimarchi, G R ^b   Nistico', G ^a  

^a UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; DILTIAZEM; FLUNARIZINE; NIMODIPINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDIOGENIC SEIZURE; BLOOD LEVEL; BODY TEMPERATURE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; ANTICONVULSANTS; BAY-K-8644; BODY TEMPERATURE; CALCIUM CHANNEL BLOCKERS; DILTIAZEM; DRUG SYNERGISM; FLUNARIZINE; MICE; MICE, INBRED DBA; NIMODIPINE; PHENOBARBITAL; PHENYTOIN; SEIZURES; SUPPORT, NON-U.S. GOV'T; VALPROIC ACID; VERAPAMIL;

EID: 0026575147     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-3623(92)90051-K     Document Type: Article

References (60)

1. Effects of periferal and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats
2. The behavioural effects of the calcium agonist BAY K 8644 in the mouse: Antagonism by the calcium antagonist nifedipine
3. Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats
4. A low voltage-activated, fully inactivity Ca channel in vertebrate sensory neurones
5. Dihydropjridine binding sites regulate calcium influx through specific voltage-sensitive calcium channels in cerebellar granulae cells
6. Calcium and ischemic injury
7. Inhibition of radioligand binding to A1 adenosine receptors by Bay K 8644 and nifedipine
8. ++ uptake and amino acid neurotransmitter release in vitro
9. Effects of calcium channel inhibitors upon the efficacy of common antiepileptic drugs
10. ++ uptake into rat whole brain synaptosomes unaltered by dihydropyridine calcium antagonist
11. Phenytoin: calcium and calmodulin-dependent protein phosphorylation and neurotransmitter release
12. The calmodulin hypothesis of neurotransmission
13. Calmodulin in neurotransmitter release and synaptic function
14. Calmodulin systems in neuronal excitability: a molecular approach to epilepsy
15. A molecular approach to the calcium signal in brain: relationship to synaptic modulation and seizure discharge
16. Mechanisms of action of anticonvulsant drugs
17. Benzodiazepine inhibition of the calcium-calmodulin protein kinase system in brain membrane
18. Anticonvulsant actions of DS 103–282 pharmacological studies in rodents and the baboon
19. Anticonvulsant effects of some calcium entry blockers in DBA/2 mice
20. Anticonvulsant properties of flunarizine on reflex and generalised models of epilepsy
21. Effects of some calcium entry blockers on sound-induced seizures in DBA/2 mice
22. Augmentation by calcium channel antagonists of general anaesthetic potency in mice
23. Anticonvulsant profile of the dihydropyridine calcium channel antagonists, nitrendipine and nimodipine
24. Verapamil concentrations in cerebrospinal fluid after oral adminisytration
25. Comparative pharmacology of calcium blockers based on studies of cardiac output distribution
26. Calcium channels: direct identification with radio ligand binding studies
27. Calcium channels basic properties revealed by radioligand binding studies
28. Mechanism of action of calcium entry blockers
29. Pharmacology of calcium entry blockers
30. Phenytoin interacts with calcium channels in brain membranes
31. The pharmacology of verapamil. V. Tissue distribution of verapamil and norverapamil in rat and dog
32. ++ conductance in identified leech neurons by benzodiazepine
33. Calcium channel antagonists decrease the ethanol withdrawal syndrome
34. ++: reversal by dihydropyridine calcium channel antagonists
35. A functional correlate for the dihydropyridine binding site in rat brain
36. Multiple calcium channels and neuronal function
37. Are dihydropyridine binding sites voltage sensitive calcium channels?
38. Interectations between calcium channel compounds and adenosine systems in brain of rat
39. Adenosine receptor binding and specific receptor for calcium channel drugs
40. Regulation of (3H)nitrendipine binding: a single allosteric site for verapamil, diltiazem and prenylamine
41. The effects of excitatory amino acids on intracellular calcium in single mouse striatal neurons in vitro
42. Double-blind placebo-controlled trial of flunarizine as add-on therapy in epilepsy
43. Add-on therapy in epilepsy with calcium entry blockers
44. Interactions of the anticonvulsants diphenylhydantoin and carbamazepine with adenosine on cerebral cortical neurons
45. Interactions between adenosine and nifedipine in the rat cerebral cortex
46. Inhibition of adenosine uptake into rat brain synaptosomes by prostaglandins, benzodiazepines and other centrally active compounds
47. Drug interactions with the calcium-entry blockers
48. Calcium uptake mechanisms affected by some convulsant and anticonvulsant drugs
49. Induction of seizures in mice by intracerebroventricular administration of the calcium channel agonist BAY K 8644
50. Anticonvulsant drug mechanisms
51. Receptor regulation of calcium entry
52. Mol. Pharmac.
53. ++ channel blockers
54. Calcium entry-blockade and epilepsy
55. Effects of various calcium channel blockers on three different models of limbic seizures in rats
56. Suppression of recurrent generalized tonic-clonic seizure discharges by intraventricular perfusion of a calcium antagonist
57. Suppression of focal epileptiform discharges by intracerebroventricular perfusion of a calcium channel antagonist
58. Calcium entry blockers as cerebral protecting agents
59. Site of anticonvulsant action on sodium channels: Autoradiographic and electrophysiological studies in rat brain